Clinical Trials

Trials are being held to evaluate the efficacy of HSCT for MS. 

MIST

MIST is the first ever international large scale randomised trial into autologous haematopoietic stem cell transplantation (AHSCT) in relapsing remitting multiple sclerosis (MS)

Read More